Key statistics
As of last trade, Anika Therapeutics Inc (ANIK:NSQ) traded at 10.39, 31.99% above the 52 week low of 7.87 set on Jul 31, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 10.24 |
|---|---|
| High | 10.39 |
| Low | 10.22 |
| Bid | 10.36 |
| Offer | 10.39 |
| Previous close | 10.21 |
| Average volume | 107.64k |
|---|---|
| Shares outstanding | 14.42m |
| Free float | 13.72m |
| P/E (TTM) | 10.84 |
| Market cap | 147.24m USD |
| EPS (TTM) | 0.9419 USD |
Data delayed at least 15 minutes, as of Feb 17 2026 17:16 GMT.
More ▼
- Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
- Anika Therapeutics Announces Leadership Transition
- Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study
- Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
- Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
